Review of Statistical Methods for Biomarker-Driven Clinical Trials
1R Simon Consulting, Potomac, MD.
JCO Precision Oncology
|February 1, 2022
Summary
New clinical trial designs, including basket and platform trials, are emerging to optimize molecularly targeted treatments. These adaptive strategies address patient heterogeneity and improve the development of precision medicines.
Area of Science:
- Oncology
- Clinical Trial Design
- Biomarker Development
Background:
- Discovery of somatic driver mutations in kinases and receptors drives development of targeted therapies.
- Targeted treatments necessitate companion diagnostics and innovative clinical development approaches.
- Traditional clinical trial designs may not adequately address patient heterogeneity for targeted therapies.
Purpose of the Study:
- To review novel clinical trial designs for molecularly targeted treatments.
- To discuss the development and validation of predictive biomarkers for treatment optimization.
- To examine statistical methods for adaptive, biomarker-driven clinical trials.
Main Methods:
- Review of phase II basket and platform trials.
- Analysis of phase III enrichment and biomarker adaptive designs.
- Examination of statistical methods for adaptive clinical trials and genome-wide data analysis.
Main Results:
- Development of adaptive designs like basket, platform, enrichment, and biomarker adaptive trials.
- Validation of predictive biomarkers as a paradigm for optimizing treatment subsets.
- Emergence of new statistical methods for adaptive trials and genome-wide data analysis.
Conclusions:
- Adaptive clinical trial designs are crucial for optimizing molecularly targeted treatments.
- Addressing patient heterogeneity through novel trial designs enhances therapeutic efficacy.
- Biomarker-driven strategies represent a new paradigm for precision medicine development.
Related Concept Videos
01:16Clinical Trials
9.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
9.5K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
190
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
190
01:20Comparing the Survival Analysis of Two or More Groups
332
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
332
01:24Kaplan-Meier Approach
295
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
295
01:11Clinical Trials: Overview
3.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.7K
01:25Statistical Methods for Analyzing Epidemiological Data
591
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
591